You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2 genetic alterations

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-Positive Cancer Trial in Wuhan

Active, not recruiting
  • HER2-Positive Cancer
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 7, 2022

    Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

    Recruiting
    • Hormone Receptor Positive Breast Carcinoma
    • +6 more
    • Liquid biopsy and CT scan
    • Bergame, Bergamo, Italy
    • +6 more
    Apr 13, 2023

    Tumor Molecular Profiling in Patients With Prostate Cancer

    Completed
    • Prostate Cancer
    • Metastatic Prostate Adenocarcinoma
    • Tumor molecular profiling
    • Athens, Greece
      Hellenic Cooperative Oncology Group
    Oct 17, 2022

    Dissection of Molecular and Immunological Interaction in HCC of

    Not yet recruiting
    • Hepatocellular Carcinoma
      • Tainan, Taiwan
      • +2 more
      Nov 6, 2022

      Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

      Recruiting
      • Solid Tumor
      • Haematological Malignancy
      • Belfast, United Kingdom
      • +24 more
      Jan 31, 2023

      Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

      Recruiting
      • Anatomic Stage IV Breast Cancer AJCC v8
      • +2 more
      • Los Angeles, California
      • +4 more
      Jul 19, 2022

      Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

      Enrolling by invitation
      • Breast Cancer
      • +7 more
      • Dnipro, Ukraine
      • +1 more
      Jun 17, 2023

      Molecular Profiling Project

      Recruiting
      • Lung Cancer
      • Non-Small Cell Lung Cancer
        • Brunei, Brunei Darussalam
        • +9 more
        Oct 2, 2022

        Breast Cancer Trial in Nanjing (stool and blood collection)

        Recruiting
        • Breast Cancer
        • stool and blood collection
        • Nanjing, Jiangsu, China
          Jiangsu Provincial People's Hospital
        Jul 5, 2022

        Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

        Active, not recruiting
        • Advanced Breast Cancer
        • +2 more
        • Talazoparib Tosylate
        • Stanford, California
          Stanford University Hospitals and Clinics
        Nov 16, 2022

        HER2-positive Breast Cancer, Chemo Effect, Circulating Tumor DNA Trial in Seoul (LiquidSCAN(Trade Mark) / CancerSCAN(Trade

        Active, not recruiting
        • HER2-positive Breast Cancer
        • +2 more
        • LiquidSCAN(Trade Mark) / CancerSCAN(Trade Mark)
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Feb 18, 2020

        ful Mutations in Solid Tumor Characterized by Next Generation

        Recruiting
        • Solid Tumor
        • +13 more
          • Aviano, Pordonone, Italy
            IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
          Sep 8, 2023

          Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer Trial in Worldwide (Infigratinib, Placebo)

          Recruiting
          • Upper Tract Urothelial Carcinomas
          • Urothelial Bladder Cancer
          • Tucson, Arizona
          • +133 more
          Apr 25, 2022

          Human Mitochondrial Stress-driven Obesity Resistance

          Recruiting
          • Mitochondrial Diseases
          • +2 more
            • Copenhagen, Denmark
              Rigshospitalet
            Oct 16, 2023

            Lung Cancer Trial in Brampton (Questionnaires)

            Recruiting
            • Lung Cancer
            • Questionnaires
            • Brampton, Ontario, Canada
              Milena (Lynn) Vicente
            Jun 17, 2022

            Solid Tumor Trial in Worldwide (BDTX-189)

            Terminated
            • Solid Tumor
            • Scottsdale, Arizona
            • +37 more
            Oct 13, 2022

            Breast Cancer Trial in Italy (Ribociclib, Letrozole, Alpelisib)

            Active, not recruiting
            • Breast Cancer
            • Casale Monferrato, AL, Italy
            • +40 more
            Dec 3, 2021

            Metastatic Breast Cancer Trial in Spain (Ipatasertib, Trastuzumab, Pertuzumab)

            Recruiting
            • Metastatic Breast Cancer
            • Badalona, Barcelona, Spain
            • +9 more
            Oct 24, 2022

            Solid Tumors, Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter Trial in Spain, United States (PRN1371)

            Terminated
            • Solid Tumors
            • Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter
            • San Francisco, California
            • +11 more
            Dec 23, 2020

            Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Puerto Rico, United States (Ivosidenib)

            Recruiting
            • Recurrent Ependymoma
            • +32 more
            • Birmingham, Alabama
            • +173 more
            Jan 27, 2023

            Esophageal Cancer Trial in Tainan, Taipei

            Recruiting
            • Esophageal Cancer
              • Tainan, Taiwan
              • +1 more
              Apr 5, 2022

              Chronic and Asymptomatic Pain Patients

              Recruiting
              • Chronic Pain
              • BDNF analysis (Elisa KIT)
              • Madrid, Spain
                Irf Cseuls
              Feb 18, 2023

              Epiction of Genomic and Genetic Landscape Identifies CCL5

              Completed
              • Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
                • (no location specified)
                Jan 27, 2023

                Rare Malignant Tumor Trial (Imatinib)

                Not yet recruiting
                • Rare Malignant Neoplasm
                • (no location specified)
                Nov 1, 2023

                Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)

                Active, not recruiting
                • Triple Negative Breast Cancer
                • London, United Kingdom
                  Barts Health NHS Trust
                Aug 10, 2022